STATEWIDE (Nov. 24, 2021) — Colorado’s Chief Medical Officer, Dr. Eric France, signed a standing order on Tuesday evening (November 23, 2021) to allow for eligible individuals to access monoclonal antibody treatments at state-run treatment sites without a referral and in accordance with established protocols. This is another step the state is taking to remove barriers to access and increase treatment options for COVID-19 patients as the current increase in cases continues to impact health care systems statewide.
In conjunction with Public Health Order 21-02, the standing order clears the way for self-scheduling options at state-run treatment sites. In this case, if the patient who is COVID-19 positive meets the eligibility criteria, the patient does not need a referral from a health care provider to access treatment at the state’s mobile monoclonal antibody treatment sites. Appointments are still required. Read more about COVID-19 treatments available in Colorado and how to get treatment at covid19.colorado.gov.
Standing orders are written medical protocols that authorize designated members of the health care team (e.g., nurses or medical assistants) to complete certain clinical tasks for individuals who meet the eligibility criteria without having to first obtain a physician order or authorization that is specific to an individual patient.
COVID-19 monoclonal antibodies can help prevent severe illness for some people who get infected with COVID-19. The FDA has authorized these neutralizing antibody treatments for emergency use. The treatments are available to people who have tested positive for COVID-19, have mild to moderate symptoms, and who are at high risk of developing severe illness (see the list of conditions that make a person eligible to receive antibody treatments). Monoclonal antibody treatments are not a substitute for vaccination.
Continue to stay up to date by visiting covid19.colorado.gov.